Clinical trial Recruiting at 1 site Interventional Ages 5 Months to 7 Months

Universal newborn hearing screening in Kenya using smartphone tests

Official title: mHealth OAE: Towards Implementation of Universal Newborn Hearing Screening in Kenya - R33 Phase (mTUNE-R33)

Run by University of Washington · NCT07879326 · Data updated 2026-11-12

This study tests whether smartphone hearing screening can help identify ear infections and hearing loss in infants, including those exposed to HIV, over 6 months.

Quick facts

Study typeInterventional
Ages5 Months to 7 Months
SexAll
Enrollment400 (estimated)
SponsorUniversity of Washington
Academic / other
Locations1 site (Nairobi)
StatusRecruiting
StartedSeptember 24, 2026
Main results expectedSeptember 2028
Study endsSeptember 2028
Registry record updatedOctober 16, 2026
Trial IDNCT07879326 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are biological mothers planning to reside in the study catchment for 6 months and their 5- to 7-month-old infants, including HIV-exposed infants.

Probably not a fit

Infants whose guardians decline participation or who move out of the catchment area during the study may not benefit from this approach.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study evaluates the accuracy of smartphone otoacoustic emissions screening compared with conventional methods in infants aged 5 to 7 months. It aims to determine the incidence of otitis media with effusions and abnormal hearing screening findings in infants with and without HIV exposure. Infants and their biological mothers will be followed for 6 months with three clinic visits, using both smartphone and standard devices to assess hearing and ear health. The findings may clarify the utility of smartphone screening as a scalable tool in this population. Exploratory analyses will consider whether HIV exposure modifies risk for otitis media with effusions.

Why it matters

Potential benefit: If successful, smartphone screening could offer a cheaper, more accessible way to detect hearing problems and ear infections in infants.

How similar studies have gone: Prior work suggests smartphone-based hearing screening can mirror conventional tests in some settings, but this study adds data in HIV-exposed infants and during infancy.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Is at least 18 years old
* Is a biological mother for the infant participant
* Willing to disclose HIV status with confirmation from medical record
* Planning to reside in the study catchment for the next 6 months

Infants must meet all of the following criteria:

* Age 5 to 7 months
* at least one patent ear canal

Exclusion Criteria:

• Unwilling to provide locator information for contact

Where it's running

  • Mathare North Health Centre
    Nairobi, Kenya
    Recruiting

Study contacts

  • Principal investigator: Sarah Benki-Nugent, PhD — University of Washington
  • Study coordinator: Sarah Benki-Nugent, PhD
  • Email: benki@u.washington.edu
  • Phone: 206-685-9713

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.